Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 92 pseudogene (ENSG00000258671) is classified as a pseudogene, meaning it is a segment of DNA derived from the functional transmembrane protein 92 gene but contains disabling mutations (such as stop codons or frameshifts) which prevent it from encoding an active protein[1][5][8]. Pseudogenes are generally viewed as non-functional genomic elements, although some may play regulatory roles at the RNA level, these functions have not been demonstrated for this pseudogene specifically. The designation "pseudogene" indicates that it is not translated into a functional transmembrane protein and is not considered a receptor, enzyme, or target for pharmacological intervention[1][8]. Pseudogenes are important for evolutionary studies but do not typically serve as drug targets or have known mechanisms of action, roles in disease, or pharmaceutical relevance[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 92 pseudogene (TMEM92P).